92 results
Page 2 of 5
8-K
EX-99.1
854ai6m edsnf
3 May 23
Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
4:05pm
S-3ASR
EX-1.2
kwg56i9mc5h1lop9
2 Nov 22
Automatic shelf registration
4:43pm
8-K
EX-99.1
e6uljfzxpfx9d47yyjt2
2 Nov 22
Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase
4:16pm
SC TO-I
EX-99
vb35vqemntfsg54dri
21 Jun 22
Issuer tender offer statement
9:05am
SC TO-I
EX-99
75y0wtrp
21 Jun 22
Issuer tender offer statement
9:05am
SC TO-I
EX-99
h19j8tj7k
21 Jun 22
Issuer tender offer statement
9:05am
8-K
EX-99.1
9ff9gg 3t3o9fj
4 May 22
Allogene Therapeutics Reports First Quarter 2022 Financial Results
4:09pm
PRE 14A
og38gekq1o
14 Apr 22
Preliminary proxy
4:10pm
8-K
EX-99.1
94m40s
23 Feb 22
Allogene Therapeutics Reports Fourth Quarter and Full Year 2021
4:08pm
8-K
EX-99.1
l1r jqmg04kmn
4 Nov 21
Allogene Therapeutics Reports Third Quarter 2021 Financial Results and Business Update
4:13pm
8-K
EX-99.1
yn3 rwhb5
4 Aug 21
Allogene Therapeutics Reports Second Quarter 2021 Financial Results
4:37pm